English
|
中文
HOME
NEWS
EVENTS
Conference
Exhibition
Laws & Regulations
About Us
CAIVD & CPCEM
CAIVD
CPCEM
VIEW
About VIEW
Editorial Board
Contact
Search
News
Home
>
News
In Vitro Diagnostic Industry in China - POCT III
2025-06-10
2. Dry Chemical Technology The biggest difference between “dry chemistry” and traditional “wet chemistry” (i.e., solution chemistry) is the media involved in the chemical reactions. In this method, the liqui..
IVD China last week: Thermo Fisher and Biomobio, Wondfo, Randox and Realbio, BD Medical
2025-06-09
Thermo Fisher and Biomobio Sign Strategic Agreement in Spatial Imaging Thermo Fisher Scientific and Biomobio have successfully concluded a strategic cooperation agreement for the EVOS S1000..
IVD China last week: Fapon and KIVDA, Agilent and MEGAROBO, WeGoBP
2025-05-27
Fapon and KIVDA Sign Strategic Agreement to Deepen China-Korea IVD Collaboration On 23 May, Fapon Biotech signed a strategic cooperation agreement with the Korea In Vitro Diagnostics Associ..
Xi arrives in Hanoi for state visit to Vietnam
2025-04-15
Chinese President Xi Jinping arrived in Hanoi on Monday to pay a state visit to Vietnam.
AdvaMed continues pressure on White House to exempt devices from tariffs
2025-04-09
AdvaMed and nine other healthcare organizations have continued to pressure the White House to exempt medical devices and critical supplies from the Trump administration’s ongoing tariff saga.
Switzerland Global Enterprise Visits CAIVD during CIIE to Foster Sino-Swiss Collaboration in In Vitro Diagnostics
2024-11-15
At the 7th China International Import Expo (CIIE), themed "New Era, Shared Future", representatives from 152 countries, regions, and organizations gathered for national and corporate exhibitions. On 8 November, Switze..
Fulgent Genetics' Germline NGS Testing Service Obtains CE-IVDR Mark
2025-07-18
Fulgent Genetics announced on Thursday that it has obtained the CE-IVDR mark for its germline next-generation sequencing service.
Abbott Reports Second-Quarter 2025 Results
2025-07-18
Original from: Abbott Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2025. · Second-quarter sales increased 7.4 percent on a reported basis, 6.9..
Thermo Fisher Scientific and Sanofi Expand Strategic Partnership to Enable Additional U.S. Drug Product Manufacturing
2025-07-17
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced an expansion of their strategic partnership with Sanofi to enable additional U.S. drug product manufacturing. The terms of the deal were not disclosed.
FDA Proposes End to Hepatitis B Surface Antigen Test Requirement for Donated Blood
2025-07-17
To the cheers of blood centers, the US Food and Drug Administration said this week that it plans to eliminate a requirement to screen donated blood with hepatitis B virus surface antigen testing when two other testing methods are also used.
National Economy Made Steady Improvement Despite Challenges in the First Half Year
2025-07-16
Original from: National Bureau of Statistics of China National Bureau of Statistics of China 15 July, 2025 In the first half year, under the strong leadership of the Central Committee of the ..
WHO prequalifies the first triple diagnostic test for HIV, hepatitis B and syphilis, a milestone toward global disease elimination goals
2025-07-16
On 10 July 2025, the World Health Organization (WHO) prequalified the first bundled set of three in vitro rapid diagnostic tests (RDTs) capable of simultaneously detecting HIV, hepatitis B virus (HBV) and syphilis – three major infections that pose serious risks to maternal and child health.
In Vitro Diagnostic Industry in China - POCT VIII
2025-07-15
1.1 Blood Glucose The latest IDF Diabetes Atlas (2025) reports that diabetes affects 589 million adults (20-79 years) around the world in 2024, with over 4 in 10 unaware that they have the condition. Over 4 in 5..
IVD China last week: PerkinElmer, Dirui, Sinocare, Adicon, Health Gene and Biofast
2025-07-15
PerkinElmer Launches New R&D and Manufacturing Base in China On July, PerkinElmer officially inaugurated its new Taicang-based R&D and manufacturing base, global procurement center..
QuidelOrtho and BÜHLMANN Laboratories AG Announce Availability of Fecal Calprotectin (fCAL®) Turbo and Fecal Pancreatic Elastase (fPELA®) Turbo Assays on VITROS™ Systems as a MicroTip™ Partnership Assay (MPA)
2025-07-15
QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho") and BÜHLMANN Laboratories AG today announced the availability of the BÜHLMANN fCAL turbo and fPELA turbo assays on QuidelOrtho's VITROS Systems as an MPA. Both particle-enhanced turbidimetric immunoassays, the fCAL turbo assay for fecal calprotectin measurement aids in the diagnosis of inflammatory bowel disease (IBD) and its differentiation from irritable bowel syndrome, and the fPELA turbo assay for fecal pancreatic elastase aids in the determination of pancreatic insufficiency.
Total:
3341
Pages:
223
First
Prev
1
2
3
4
..
223
Next
End